BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
STERIMAX INC
Quick answers
Is there a shortage of BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP in Canada?
No. There is no current shortage of BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP 7.5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
BUPIVACAINE HYDROCHLORIDE INJECTION USP .75%
HOSPIRA HEALTHCARE ULC
MARCAINE 0.75% LIQ SPINAL 7.5MG/ML
SANOFI CANADA, INC.
MARCAINE 0.75% LIQ PRT 7.5MG/ML
SANOFI CANADA, INC.
SENSORCAINE
ASPEN PHARMACARE CANADA INC.
BUPIVACAINE HYDROCHLORIDE INJECTION USP .50%
HOSPIRA HEALTHCARE ULC
BUPIVACAINE HYDROCHLORIDE INJECTION USP .25%
HOSPIRA HEALTHCARE ULC
DIN
02460645
Strength
7.5MG
Dosage Form
SOLUTION
Route
INTRASPINAL
Compare with another product →
Shortage History
Other Products from STERIMAX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02358328
200MG · DIN 02538431
50MG · DIN 02456524
20MG · DIN 00723754
1MG · DIN 02492768
500MG · DIN 02483890
50000UNIT · DIN 02245571
10MG · DIN 02413647
10MG · DIN 02413639
0.05MG · DIN 02413620
7.5MG · DIN 02504979
5MG · DIN 02443694